359 related articles for article (PubMed ID: 31428091)
21. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.
Mantovani A; Valentino S; Gentile S; Inforzato A; Bottazzi B; Garlanda C
Ann N Y Acad Sci; 2013 May; 1285():1-14. PubMed ID: 23527487
[TBL] [Abstract][Full Text] [Related]
22. Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3.
Lech M; Rommele C; Anders HJ
Nephrol Dial Transplant; 2013 Apr; 28(4):803-11. PubMed ID: 23243042
[TBL] [Abstract][Full Text] [Related]
23. Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation.
Wang L; Cano M; Datta S; Wei H; Ebrahimi KB; Gorashi Y; Garlanda C; Handa JT
J Pathol; 2016 Dec; 240(4):495-506. PubMed ID: 27659908
[TBL] [Abstract][Full Text] [Related]
24. Pentraxins in invertebrates and vertebrates: From structure, function and evolution to clinical applications.
Wang Y; Chen W; Ding S; Wang W; Wang C
Dev Comp Immunol; 2023 Dec; 149():105064. PubMed ID: 37734429
[TBL] [Abstract][Full Text] [Related]
25. Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization.
Kárpáti É; Papp A; Schneider AE; Hajnal D; Cserhalmi M; Csincsi ÁI; Uzonyi B; Józsi M
Front Immunol; 2020; 11():1297. PubMed ID: 32765490
[TBL] [Abstract][Full Text] [Related]
26. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
27. Structural recognition and functional activation of FcgammaR by innate pentraxins.
Lu J; Marnell LL; Marjon KD; Mold C; Du Clos TW; Sun PD
Nature; 2008 Dec; 456(7224):989-92. PubMed ID: 19011614
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein and pentraxin-3 binding of factor H-like protein 1 differs from complement factor H: implications for retinal inflammation.
Swinkels M; Zhang JH; Tilakaratna V; Black G; Perveen R; McHarg S; Inforzato A; Day AJ; Clark SJ
Sci Rep; 2018 Jan; 8(1):1643. PubMed ID: 29374201
[TBL] [Abstract][Full Text] [Related]
29. Human pentraxin 3 binds to the complement regulator c4b-binding protein.
Braunschweig A; Józsi M
PLoS One; 2011; 6(8):e23991. PubMed ID: 21915248
[TBL] [Abstract][Full Text] [Related]
30. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity.
Gershov D; Kim S; Brot N; Elkon KB
J Exp Med; 2000 Nov; 192(9):1353-64. PubMed ID: 11067883
[TBL] [Abstract][Full Text] [Related]
31. Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants.
Bally I; Inforzato A; Dalonneau F; Stravalaci M; Bottazzi B; Gaboriaud C; Thielens NM
Front Immunol; 2019; 10():461. PubMed ID: 30923526
[TBL] [Abstract][Full Text] [Related]
32. Pentraxins and Fc receptors.
Lu J; Marjon KD; Mold C; Du Clos TW; Sun PD
Immunol Rev; 2012 Nov; 250(1):230-8. PubMed ID: 23046133
[TBL] [Abstract][Full Text] [Related]
33. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens.
Du Clos TW
Mol Biol Rep; 1996; 23(3-4):253-60. PubMed ID: 9112237
[TBL] [Abstract][Full Text] [Related]
34. Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration.
Stravalaci M; Davi F; Parente R; Gobbi M; Bottazzi B; Mantovani A; Day AJ; Clark SJ; Romano MR; Inforzato A
Front Pharmacol; 2020; 11():591908. PubMed ID: 33324220
[TBL] [Abstract][Full Text] [Related]
35. Serum amyloid P component binds to histones and activates the classical complement pathway.
Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
[TBL] [Abstract][Full Text] [Related]
36. Ayu C-reactive protein/serum amyloid P agglutinates bacteria and inhibits complement-mediated opsonophagocytosis by monocytes/macrophages.
Shi YH; Chen K; Ma WJ; Chen J
Fish Shellfish Immunol; 2018 May; 76():58-67. PubMed ID: 29481847
[TBL] [Abstract][Full Text] [Related]
37. Pentraxins and Fc Receptor-Mediated Immune Responses.
Lu J; Mold C; Du Clos TW; Sun PD
Front Immunol; 2018; 9():2607. PubMed ID: 30483265
[TBL] [Abstract][Full Text] [Related]
38. Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.
Augusto JF; Poli C; Beauvillain C; Subra JF; Jaillon S; Renier G; Chevailler A; Puéchal X; Delneste Y; Jeannin P
Int Rev Immunol; 2017 May; 36(3):145-153. PubMed ID: 28471269
[TBL] [Abstract][Full Text] [Related]
39. Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.
Kravitz MS; Pitashny M; Shoenfeld Y
J Clin Immunol; 2005 Nov; 25(6):582-91. PubMed ID: 16380821
[TBL] [Abstract][Full Text] [Related]
40. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.
Jarva H; Jokiranta TS; Hellwage J; Zipfel PF; Meri S
J Immunol; 1999 Oct; 163(7):3957-62. PubMed ID: 10490997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
